<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">problendo</journal-id><journal-title-group><journal-title xml:lang="ru">Проблемы Эндокринологии</journal-title><trans-title-group xml:lang="en"><trans-title>Problems of Endocrinology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0375-9660</issn><issn pub-type="epub">2308-1430</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/probl13648</article-id><article-id custom-type="elpub" pub-id-type="custom">problendo-13648</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Онкоэндокринология</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Oncoendocrinology</subject></subj-group></article-categories><title-group><article-title>Особенности биоэнергетического метаболизма в физиологических и патологических условиях: фокус на онкогенез</article-title><trans-title-group xml:lang="en"><trans-title>Features of bioenergetic metabolism in physiological and pathological conditions: focus on oncogenesis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2948-5019</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жданова</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhdanova</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жданова Анастасия Станиславовна, аспирант </p><p>117036, г. Москва, ул. Дм. Ульянова, д. 11 </p></bio><bio xml:lang="en"><p>Anastasiia S. Zhdanova, PhD student</p><p>117036, Moscow, Dmitria Uljanova street, 11</p></bio><email xlink:type="simple">zhdanova.a.doc@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6674-6441</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Белая</surname><given-names>Ж. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Belaya</surname><given-names>Z. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Белая Жанна Евгеньевна, д.м.н., профессор </p><p>Москва</p></bio><bio xml:lang="en"><p>Zhanna E. Belaya, MD, PhD</p><p>Moscow</p></bio><email xlink:type="simple">jannabelaya@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5634-7877</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мельниченко</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Melnichenko</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мельниченко Галина Афанасьевна, д.м.н., профессор, академик РАН </p><p>Москва</p></bio><bio xml:lang="en"><p>Galina A. Melnichenko, MD, PhD, acad.</p><p>Moscow</p></bio><email xlink:type="simple">teofrast2000@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Национальный медицинский исследовательский центр эндокринологии им. академика И.И. Дедова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>18</day><month>01</month><year>2026</year></pub-date><volume>71</volume><issue>6</issue><fpage>56</fpage><lpage>66</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жданова А.С., Белая Ж.Е., Мельниченко Г.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Жданова А.С., Белая Ж.Е., Мельниченко Г.А.</copyright-holder><copyright-holder xml:lang="en">Zhdanova A.S., Belaya Z.E., Melnichenko G.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.probl-endojournals.ru/jour/article/view/13648">https://www.probl-endojournals.ru/jour/article/view/13648</self-uri><abstract><p>В основе жизнедеятельности каждой клетки организма лежит энергетический обмен, необходимый для реализации физиологических потребностей в норме и при патологии. Важнейшими путями синтеза аденозинтрифосфата являются гликолиз, цикл трикарбоновых кислот и окислительное фосфорилирование. В качестве субстрата для получения энергии могут быть использованы глюкоза, свободные жирные кислоты и аминокислоты. При развитии заболевания в клетках происходит перепрограммирование с возможностью переключения между путями получения энергии и выбором ее источников, формируя специфический метаболический фенотип, обеспечивающий выживание клеток и формирование клинических характеристик болезни. Наличие информации о патофизиологических изменениях на уровне метаболизма клеток представляет научно-практический интерес в отношении разработки методов для точной диагностики и выбора персонализированной тактики в каждом конкретном случае. В представленном обзоре охарактеризованы особенности энергетического метаболизма в норме и в опухолевых клетках. Собрана информация о современных методах оценки уровня энергообмена в организме.</p></abstract><trans-abstract xml:lang="en"><p>The basis of the vital activity of each cell of the body is energy metabolism, necessary for the implementation of physiological needs in norm and pathology. The most important pathways for the synthesis of adenosine triphosphate are glycolysis, the tricarboxylic acid cycle and oxidative phosphorylation. Glucose, free fatty acids and amino acids can be used as a substrate for obtaining energy. As the disease develops, reprogramming occurs in cells with the ability to switch between energy pathways and the choice of its sources, forming a specific metabolic phenotype that ensures cell survival and the formation of clinical characteristics of the disease. The availability of information on pathophysiological changes at the level of cell metabolism is of scientific and practical interest in relation to the development of methods for accurate diagnosis and the choice of personalized tactics in each specific case. This review describes the characteristics of energy metabolism in normal and tumor cells. It also provides information on modern methods for assessing energy metabolism in the body.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>энергообмен</kwd><kwd>клетка</kwd><kwd>гликолиз</kwd><kwd>окислительное фосфорилирование</kwd><kwd>опухоль</kwd><kwd>нейроэндокринные образования</kwd><kwd>диагностика</kwd></kwd-group><kwd-group xml:lang="en"><kwd>energy metabolism</kwd><kwd>cell</kwd><kwd>glycolysis</kwd><kwd>oxidative phosphorylation</kwd><kwd>tumor</kwd><kwd>neuroendocrine neoplasms</kwd><kwd>diagnostics</kwd></kwd-group></article-meta></front><back><ref-list><ref id="cit1"><element-citation><name><surname>Liu</surname> <given-names>Hui</given-names> </name> <name><surname>Wang</surname> <given-names>Shuo</given-names> </name> <name><surname>Wang</surname> <given-names>Jianhua</given-names> </name> <name><surname>Guo</surname> <given-names>Xin</given-names> </name> <name><surname>Song</surname> <given-names>Yujing</given-names> </name> <name><surname>Fu</surname> <given-names>Kun</given-names> </name> <name><surname>Gao</surname> <given-names>Zhenjie</given-names> </name> <name><surname>Liu</surname> <given-names>Danfeng</given-names> </name> <name><surname>He</surname> <given-names>Wei</given-names> </name> <name><surname>Yang</surname> <given-names>Lei-Lei</given-names> </name> <article-title>Energy metabolism in health and diseases</article-title> <source>Signal Transduction and Targeted Therapy</source> <year>2025</year> <month>02</month> <volume>10</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1038/s41392-025-02141-x</object-id></element-citation></ref><ref id="cit2"><element-citation><name><surname>Lakhani</surname> <given-names>Aliya</given-names> </name> <name><surname>Kang</surname> <given-names>Da Hyun</given-names> </name> <name><surname>Kang</surname> <given-names>Yea Eun</given-names> </name> <name><surname>Park</surname> <given-names>Junyoung O.</given-names> </name> <article-title>Toward Systems-Level Metabolic Analysis in Endocrine Disorders and Cancer</article-title> <source>Endocrinology and Metabolism</source> <year>2023</year> <month>11</month> <fpage>619</fpage> <lpage>630</lpage> <volume>38</volume> <issue>6</issue> <object-id pub-id-type="doi" specific-use="metadata">10.3803/enm.2023.1814</object-id></element-citation></ref><ref id="cit3"><element-citation><name><surname>Sautchuk</surname> <given-names>Rubens</given-names> </name> <name><surname>Eliseev</surname> <given-names>Roman A.</given-names> </name> <article-title>Cell energy metabolism and bone formation</article-title> <source>Bone Reports</source> <year>2022</year> <month>05</month> <fpage>101594</fpage> <volume>16</volume> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.bonr.2022.101594</object-id></element-citation></ref><ref id="cit4"><element-citation><name><surname>Da</surname> <given-names>Wacili</given-names> </name> <name><surname>Tao</surname> <given-names>Lin</given-names> </name> <name><surname>Zhu</surname> <given-names>Yue</given-names> </name> <article-title>The Role of Osteoclast Energy Metabolism in the Occurrence and Development of Osteoporosis</article-title> <source>Frontiers in Endocrinology</source> <year>2021</year> <month>05</month> <volume>12</volume> <object-id pub-id-type="doi" specific-use="metadata">10.3389/fendo.2021.675385</object-id></element-citation></ref><ref id="cit5"><element-citation><name><surname>Pouysségur</surname> <given-names>J.</given-names> </name> <name><surname>Marchiq</surname> <given-names>I.</given-names> </name> <name><surname>Parks</surname> <given-names>S.K.</given-names> </name> <name><surname>Durivault</surname> <given-names>J.</given-names> </name> <name><surname>Ždralević</surname> <given-names>M.</given-names> </name> <name><surname>Vucetic</surname> <given-names>M.</given-names> </name> <article-title>‘Warburg effect’ controls tumor growth, bacterial, viral infections and immunity – Genetic deconstruction and therapeutic perspectives</article-title> <source>Seminars in Cancer Biology</source> <year>2022</year> <month>07</month> <fpage>334</fpage> <lpage>346</lpage> <volume>86</volume> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.semcancer.2022.07.004</object-id></element-citation></ref><ref id="cit6"><element-citation><name><surname>Hu</surname> <given-names>Chunhua</given-names> </name> <name><surname>Chen</surname> <given-names>Lingyi</given-names> </name> <name><surname>Ding</surname> <given-names>Yi</given-names> </name> <name><surname>Ye</surname> <given-names>Mujie</given-names> </name> <name><surname>Tang</surname> <given-names>Qiyun</given-names> </name> <article-title>Metabolic changes in neuroendocrine neoplasms</article-title> <source>Cellular and Molecular Life Sciences</source> <year>2025</year> <month>05</month> <volume>82</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/s00018-025-05656-2</object-id></element-citation></ref><ref id="cit7"><element-citation><name><surname>Pavlova</surname> <given-names>Natalya N.</given-names> </name> <name><surname>Thompson</surname> <given-names>Craig B.</given-names> </name> <article-title>The Emerging Hallmarks of Cancer Metabolism</article-title> <source>Cell Metabolism</source> <year>2016</year> <month>01</month> <fpage>27</fpage> <lpage>47</lpage> <volume>23</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.cmet.2015.12.006</object-id></element-citation></ref><ref id="cit8"><element-citation><name><surname>Lukina</surname> <given-names>M.M.</given-names> </name> <name><surname>Shirmanova</surname> <given-names>M.V.</given-names> </name> <name><surname>Sergeeva</surname> <given-names>T.F.</given-names> </name> <name><surname>Zagaynova</surname> <given-names>E.V.</given-names> </name> <article-title>Metabolic Imaging in the Study of Oncological Processes (Review)</article-title> <source>Sovremennye tehnologii v medicine</source> <year>2016</year> <month>12</month> <fpage>113</fpage> <lpage>126</lpage> <volume>8</volume> <issue>4</issue> <object-id pub-id-type="doi" specific-use="metadata">10.17691/stm2016.8.4.16</object-id></element-citation></ref><ref id="cit9"><element-citation><name><surname>Pavlova</surname> <given-names>Natalya N.</given-names> </name> <name><surname>Zhu</surname> <given-names>Jiajun</given-names> </name> <name><surname>Thompson</surname> <given-names>Craig B.</given-names> </name> <article-title>The hallmarks of cancer metabolism: Still emerging</article-title> <source>Cell Metabolism</source> <year>2022</year> <month>02</month> <fpage>355</fpage> <lpage>377</lpage> <volume>34</volume> <issue>3</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.cmet.2022.01.007</object-id></element-citation></ref><ref id="cit10"><element-citation><name><surname>Liu</surname> <given-names>Yingying</given-names> </name> <name><surname>Gu</surname> <given-names>Renjun</given-names> </name> <name><surname>Gao</surname> <given-names>Murong</given-names> </name> <name><surname>Wei</surname> <given-names>Yangwa</given-names> </name> <name><surname>Shi</surname> <given-names>Yu</given-names> </name> <name><surname>Wang</surname> <given-names>Xu</given-names> </name> <name><surname>Gu</surname> <given-names>Yihuang</given-names> </name> <name><surname>Gu</surname> <given-names>Xin</given-names> </name> <name><surname>Zhang</surname> <given-names>Hongru</given-names> </name> <article-title>Emerging role of substance and energy metabolism associated with neuroendocrine regulation in tumor cells</article-title> <source>Frontiers in Endocrinology</source> <year>2023</year> <month>03</month> <volume>14</volume> <object-id pub-id-type="doi" specific-use="metadata">10.3389/fendo.2023.1126271</object-id></element-citation></ref><ref id="cit11"><element-citation><name><surname>Zhang</surname> <given-names>Hong</given-names> </name> <name><surname>Tang</surname> <given-names>Shuang</given-names> </name> <article-title>Metabolic reprogramming and cancer precision medicine: a narrative review</article-title> <source>Precision Cancer Medicine</source> <year>2021</year> <month>11</month> <fpage>35</fpage> <lpage>35</lpage> <volume>4</volume> <object-id pub-id-type="doi" specific-use="metadata">10.21037/pcm-21-27</object-id></element-citation></ref><ref id="cit12"><element-citation><name><surname>Wang</surname> <given-names>Zhefang</given-names> </name> <name><surname>Liu</surname> <given-names>Fanyu</given-names> </name> <name><surname>Fan</surname> <given-names>Ningbo</given-names> </name> <name><surname>Zhou</surname> <given-names>Chenghui</given-names> </name> <name><surname>Li</surname> <given-names>Dai</given-names> </name> <name><surname>Macvicar</surname> <given-names>Thomas</given-names> </name> <name><surname>Dong</surname> <given-names>Qiongzhu</given-names> </name> <name><surname>Bruns</surname> <given-names>Christiane J.</given-names> </name> <name><surname>Zhao</surname> <given-names>Yue</given-names> </name> <article-title>Targeting Glutaminolysis: New Perspectives to Understand Cancer Development and Novel Strategies for Potential Target Therapies</article-title> <source>Frontiers in Oncology</source> <year>2020</year> <month>10</month> <volume>10</volume> <object-id pub-id-type="doi" specific-use="metadata">10.3389/fonc.2020.589508</object-id></element-citation></ref><ref id="cit13"><element-citation><name><surname>Feng</surname> <given-names>Tianshun</given-names> </name> <name><surname>Hou</surname> <given-names>Pengwei</given-names> </name> <name><surname>Mu</surname> <given-names>Shuwen</given-names> </name> <name><surname>Fang</surname> <given-names>Yi</given-names> </name> <name><surname>Li</surname> <given-names>Xinxiong</given-names> </name> <name><surname>Li</surname> <given-names>Ziqi</given-names> </name> <name><surname>Wang</surname> <given-names>Di</given-names> </name> <name><surname>Chen</surname> <given-names>Li</given-names> </name> <name><surname>Lu</surname> <given-names>Lingling</given-names> </name> <name><surname>Lin</surname> <given-names>Kunzhe</given-names> </name> <name><surname>Wang</surname> <given-names>Shousen</given-names> </name> <article-title>Identification of cholesterol metabolism-related subtypes in nonfunctioning pituitary neuroendocrine tumors and analysis of immune infiltration</article-title> <source>Lipids in Health and Disease</source> <year>2023</year> <month>08</month> <volume>22</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1186/s12944-023-01883-3</object-id></element-citation></ref><ref id="cit14"><element-citation> <name><surname>Kulikov</surname> <given-names>V.A.</given-names> </name> <name><surname>Belyaeva</surname> <given-names>L.E.</given-names> </name>  <article-title>Cancer cell metabolism as a therapeutic target</article-title> <source>Vestnik of Vitebsk State Medical University</source> <year>2017</year> <month>01</month> <fpage>7</fpage> <lpage>20</lpage> <volume>15</volume> <issue>6</issue> <object-id pub-id-type="doi" specific-use="metadata">10.22263/2312-4156.2016.6.7</object-id></element-citation></ref><ref id="cit15"><element-citation><name><surname>Hu</surname> <given-names>Chunhua</given-names> </name> <name><surname>Chen</surname> <given-names>Lingyi</given-names> </name> <name><surname>Ding</surname> <given-names>Yi</given-names> </name> <name><surname>Ye</surname> <given-names>Mujie</given-names> </name> <name><surname>Tang</surname> <given-names>Qiyun</given-names> </name> <article-title>Metabolic changes in neuroendocrine neoplasms</article-title> <source>Cellular and Molecular Life Sciences</source> <year>2025</year> <month>05</month> <volume>82</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/s00018-025-05656-2</object-id></element-citation></ref><ref id="cit16"><element-citation><name><surname>Menshikov</surname> <given-names>K. V.</given-names> </name> <name><surname>Sultanbaev</surname> <given-names>A. V.</given-names> </name> <name><surname>Musin</surname> <given-names>Sh. I.</given-names> </name> <name><surname>Menshikova</surname> <given-names>I. A.</given-names> </name> <name><surname>Nasretdinov</surname> <given-names>A. F.</given-names> </name> <name><surname>Sultanbaeva</surname> <given-names>N. I.</given-names> </name> <name><surname>Shaykhutdinov</surname> <given-names>I. R.</given-names> </name> <article-title>Neuroendocrine Tumours: a Literature Review</article-title> <source>Creative surgery and oncology</source> <year>2021</year> <month>05</month> <fpage>174</fpage> <lpage>182</lpage> <volume>11</volume> <issue>2</issue> <object-id pub-id-type="doi" specific-use="metadata">10.24060/2076-3093-2021-11-2-174-182</object-id></element-citation></ref><ref id="cit17"><mixed-citation publication-type="commun" publication-format="web"><name><surname>Artamonova</surname> <given-names>E.V.</given-names></name>, <name><surname>Bel'tsevich</surname> <given-names>D.G.</given-names></name>, <name><surname>Bokhyan</surname> <given-names>V.Yu.</given-names></name> i dr. <article-title>Klinicheskie rekomendatsii «Neiroendokrinnye opukholi»</article-title>. <year>2020</year>;<fpage>1</fpage>-<lpage>52</lpage>.</mixed-citation></ref><ref id="cit18"><element-citation><name><surname>Kuzminov</surname> <given-names>A.E. Kuzminov</given-names> </name> <name><surname>Gorbunova</surname> <given-names>V.A. Gorbunova</given-names> </name>  <article-title>Neuroendocrine tumors: general characteristics and features of management tactics</article-title> <source>Pharmateca</source> <year>2019</year> <month>03</month> <fpage>66</fpage> <lpage>71</lpage> <volume>12_2018</volume> <object-id pub-id-type="doi" specific-use="metadata">10.18565/pharmateca.2018.12.66-71</object-id></element-citation></ref><ref id="cit19"><element-citation><name><surname>Deroose</surname> <given-names>Christophe M.</given-names> </name> <name><surname>Hindié</surname> <given-names>Elif</given-names> </name> <name><surname>Kebebew</surname> <given-names>Electron</given-names> </name> <name><surname>Goichot</surname> <given-names>Bernard</given-names> </name> <name><surname>Pacak</surname> <given-names>Karel</given-names> </name> <name><surname>Taïeb</surname> <given-names>David</given-names> </name> <name><surname>Imperiale</surname> <given-names>Alessio</given-names> </name> <article-title>Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions</article-title> <source>Journal of Nuclear Medicine</source> <year>2016</year> <month>11</month> <fpage>1949</fpage> <lpage>1956</lpage> <volume>57</volume> <issue>12</issue> <object-id pub-id-type="doi" specific-use="metadata">10.2967/jnumed.116.179234</object-id></element-citation></ref><ref id="cit20"><element-citation><name><surname>Gronskaia</surname> <given-names>S. A.</given-names> </name> <name><surname>Belaya</surname> <given-names>Zh. E.</given-names> </name> <name><surname>Melnichenko</surname> <given-names>G. A.</given-names> </name> <article-title>FGF23 tumor induced osteomalacia</article-title> <source>Problems of Endocrinology</source> <year>2022</year> <month>11</month> <fpage>56</fpage> <lpage>66</lpage> <volume>68</volume> <issue>5</issue> <object-id pub-id-type="doi" specific-use="metadata">10.14341/probl13130</object-id></element-citation></ref><ref id="cit21"><element-citation><name><surname>Golounina</surname> <given-names>Olga O.</given-names> </name> <name><surname>Belaya</surname> <given-names>Zhanna E.</given-names> </name> <name><surname>Rozhinskaya</surname> <given-names>Liudmila Ya.</given-names> </name> <name><surname>Marova</surname> <given-names>Evgeniya I.</given-names> </name> <name><surname>Pikunov</surname> <given-names>Michail Yu.</given-names> </name> <name><surname>Khandaeva</surname> <given-names>Patimat M.</given-names> </name> <name><surname>Arapova</surname> <given-names>Svetlana D.</given-names> </name> <name><surname>Dzeranova</surname> <given-names>Larisa K.</given-names> </name> <name><surname>Kuznetsov</surname> <given-names>Nikolai S.</given-names> </name> <name><surname>Fadeev</surname> <given-names>Valentin V.</given-names> </name> <name><surname>Melnichenko</surname> <given-names>Galina A.</given-names> </name> <name><surname>Dedov</surname> <given-names>Ivan I.</given-names> </name> <article-title>Clinical and laboratory characteristics and results of treatment of patients with ACTH-producing neuroendocrine tumors of various localization</article-title> <source>Terapevticheskii arkhiv</source> <year>2021</year> <month>11</month> <fpage>1171</fpage> <lpage>1178</lpage> <volume>93</volume> <issue>10</issue> <object-id pub-id-type="doi" specific-use="metadata">10.26442/00403660.2021.10.201102</object-id></element-citation></ref><ref id="cit22"><element-citation><name><surname>Minn</surname> <given-names>Heikki</given-names> </name> <name><surname>Kauhanen</surname> <given-names>Saila</given-names> </name> <name><surname>Seppänen</surname> <given-names>Marko</given-names> </name> <name><surname>Nuutila</surname> <given-names>Pirjo</given-names> </name> <article-title><sup>18</sup>F-FDOPA: A Multiple-Target Molecule</article-title> <source>Journal of Nuclear Medicine</source> <year>2009</year> <month>11</month> <fpage>1915</fpage> <lpage>1918</lpage> <volume>50</volume> <issue>12</issue> <object-id pub-id-type="doi" specific-use="metadata">10.2967/jnumed.109.065664</object-id></element-citation></ref><ref id="cit23"><element-citation><name><surname>Montravers</surname> <given-names>Françoise</given-names> </name> <name><surname>Kerrou</surname> <given-names>Khaldoun</given-names> </name> <name><surname>Nataf</surname> <given-names>Valérie</given-names> </name> <name><surname>Huchet</surname> <given-names>Virginie</given-names> </name> <name><surname>Lotz</surname> <given-names>Jean-Pierre</given-names> </name> <name><surname>Ruszniewski</surname> <given-names>Philippe</given-names> </name> <name><surname>Rougier</surname> <given-names>Philippe</given-names> </name> <name><surname>Duron</surname> <given-names>Françoise</given-names> </name> <name><surname>Bouchard</surname> <given-names>Philippe</given-names> </name> <name><surname>Grangé</surname> <given-names>Jean-Didier</given-names> </name> <name><surname>Houry</surname> <given-names>Sydney</given-names> </name> <name><surname>Talbot</surname> <given-names>Jean-Noël</given-names> </name> <article-title>Impact of Fluorodihydroxyphenylalanine-(18F) Positron Emission Tomography on Management of Adult Patients with Documented or Occult Digestive Endocrine Tumors</article-title> <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <year>2009</year> <month>01</month> <fpage>1295</fpage> <lpage>1301</lpage> <volume>94</volume> <issue>4</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1210/jc.2008-1349</object-id></element-citation></ref><ref id="cit24"><element-citation><name><surname>Koopmans</surname> <given-names>Klaas P</given-names> </name> <name><surname>de Vries</surname> <given-names>Elisabeth GE</given-names> </name> <name><surname>Kema</surname> <given-names>Ido P</given-names> </name> <name><surname>Elsinga</surname> <given-names>Philip H</given-names> </name> <name><surname>Neels</surname> <given-names>Oliver C</given-names> </name> <name><surname>Sluiter</surname> <given-names>Wim J</given-names> </name> <name><surname>van der Horst-Schrivers</surname> <given-names>Anouk NA</given-names> </name> <name><surname>Jager</surname> <given-names>Pieter L</given-names> </name> <article-title>Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study</article-title> <source>The Lancet Oncology</source> <year>2006</year> <month>08</month> <fpage>728</fpage> <lpage>734</lpage> <volume>7</volume> <issue>9</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1016/s1470-2045(06)70801-4</object-id></element-citation></ref><ref id="cit25"><element-citation><name><surname>Panagiotidis</surname> <given-names>Emmanouil</given-names> </name> <name><surname>Alshammari</surname> <given-names>Alshaima</given-names> </name> <name><surname>Michopoulou</surname> <given-names>Sofia</given-names> </name> <name><surname>Skoura</surname> <given-names>Evangelia</given-names> </name> <name><surname>Naik</surname> <given-names>Keval</given-names> </name> <name><surname>Maragkoudakis</surname> <given-names>Emmanouil</given-names> </name> <name><surname>Mohmaduvesh</surname> <given-names>Mullan</given-names> </name> <name><surname>Al-Harbi</surname> <given-names>Mohammed</given-names> </name> <name><surname>Belda</surname> <given-names>Maria</given-names> </name> <name><surname>Caplin</surname> <given-names>Martyn E.</given-names> </name> <name><surname>Toumpanakis</surname> <given-names>Christos</given-names> </name> <name><surname>Bomanji</surname> <given-names>Jamshed</given-names> </name> <article-title>Comparison of the Impact of <sup>68</sup>Ga-DOTATATE and <sup>18</sup>F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors</article-title> <source>Journal of Nuclear Medicine</source> <year>2016</year> <month>08</month> <fpage>91</fpage> <lpage>96</lpage> <volume>58</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.2967/jnumed.116.178095</object-id></element-citation></ref><ref id="cit26"><element-citation><name><surname>Abgral</surname> <given-names>Ronan</given-names> </name> <name><surname>Leboulleux</surname> <given-names>Sophie</given-names> </name> <name><surname>Déandreis</surname> <given-names>Désirée</given-names> </name> <name><surname>Aupérin</surname> <given-names>Anne</given-names> </name> <name><surname>Lumbroso</surname> <given-names>Jean</given-names> </name> <name><surname>Dromain</surname> <given-names>Clarisse</given-names> </name> <name><surname>Duvillard</surname> <given-names>Pierre</given-names> </name> <name><surname>Elias</surname> <given-names>Dominique</given-names> </name> <name><surname>de Baere</surname> <given-names>Thierry</given-names> </name> <name><surname>Guigay</surname> <given-names>Joël</given-names> </name> <name><surname>Ducreux</surname> <given-names>Michel</given-names> </name> <name><surname>Schlumberger</surname> <given-names>Martin</given-names> </name> <name><surname>Baudin</surname> <given-names>Eric</given-names> </name> <article-title>Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging</article-title> <source>The Journal of Clinical Endocrinology &amp; Metabolism</source> <year>2010</year> <month>12</month> <fpage>665</fpage> <lpage>671</lpage> <volume>96</volume> <issue>3</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1210/jc.2010-2022</object-id></element-citation></ref><ref id="cit27"><element-citation><name><surname>Long</surname> <given-names>Niamh M.</given-names> </name> <name><surname>Smith</surname> <given-names>Clare S.</given-names> </name> <article-title>Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging</article-title> <source>Insights into Imaging</source> <year>2011</year> <month>09</month> <fpage>679</fpage> <lpage>698</lpage> <volume>2</volume> <issue>6</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/s13244-010-0062-3</object-id></element-citation></ref><ref id="cit28"><element-citation><name><surname>Imperiale</surname> <given-names>Alessio</given-names> </name> <name><surname>Poncet</surname> <given-names>Gilles</given-names> </name> <name><surname>Addeo</surname> <given-names>Pietro</given-names> </name> <name><surname>Ruhland</surname> <given-names>Elisa</given-names> </name> <name><surname>Roche</surname> <given-names>Colette</given-names> </name> <name><surname>Battini</surname> <given-names>Stephanie</given-names> </name> <name><surname>Cicek</surname> <given-names>A. Ercument</given-names> </name> <name><surname>Chenard</surname> <given-names>Marie Pierrette</given-names> </name> <name><surname>Hervieu</surname> <given-names>Valérie</given-names> </name> <name><surname>Goichot</surname> <given-names>Bernard</given-names> </name> <name><surname>Bachellier</surname> <given-names>Philippe</given-names> </name> <name><surname>Walter</surname> <given-names>Thomas</given-names> </name> <name><surname>Namer</surname> <given-names>Izzie Jacques</given-names> </name> <article-title>Metabolomics of Small Intestine Neuroendocrine Tumors and Related Hepatic Metastases</article-title> <source>Metabolites</source> <year>2019</year> <month>12</month> <fpage>300</fpage> <volume>9</volume> <issue>12</issue> <object-id pub-id-type="doi" specific-use="metadata">10.3390/metabo9120300</object-id></element-citation></ref><ref id="cit29"><element-citation> <name><surname>Beger</surname> <given-names>Richard D.</given-names> </name> <name><surname>Dunn</surname> <given-names>Warwick</given-names> </name> <name><surname>Schmidt</surname> <given-names>Michael A.</given-names> </name> <name><surname>Gross</surname> <given-names>Steven S.</given-names> </name> <name><surname>Kirwan</surname> <given-names>Jennifer A.</given-names> </name> <name><surname>Cascante</surname> <given-names>Marta</given-names> </name> <name><surname>Brennan</surname> <given-names>Lorraine</given-names> </name> <name><surname>Wishart</surname> <given-names>David S.</given-names> </name> <name><surname>Oresic</surname> <given-names>Matej</given-names> </name> <name><surname>Hankemeier</surname> <given-names>Thomas</given-names> </name> <name><surname>Broadhurst</surname> <given-names>David I.</given-names> </name> <name><surname>Lane</surname> <given-names>Andrew N.</given-names> </name> <name><surname>Suhre</surname> <given-names>Karsten</given-names> </name> <name><surname>Kastenmüller</surname> <given-names>Gabi</given-names> </name> <name><surname>Sumner</surname> <given-names>Susan J.</given-names> </name> <name><surname>Thiele</surname> <given-names>Ines</given-names> </name> <name><surname>Fiehn</surname> <given-names>Oliver</given-names> </name> <name><surname>Kaddurah-Daouk</surname> <given-names>Rima</given-names> </name> <article-title>Metabolomics enables precision medicine: “A White Paper, Community Perspective”</article-title> <source>Metabolomics</source> <year>2016</year> <month>09</month> <volume>12</volume> <issue>9</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1007/s11306-016-1094-6</object-id></element-citation></ref><ref id="cit30"><element-citation><name><surname>Kinross</surname> <given-names>James M.</given-names> </name> <name><surname>Drymousis</surname> <given-names>Panagiotis</given-names> </name> <name><surname>Jiménez</surname> <given-names>Beatriz</given-names> </name> <name><surname>Frilling</surname> <given-names>Andrea</given-names> </name> <article-title>Metabonomic profiling: A novel approach in neuroendocrine neoplasias</article-title> <source>Surgery</source> <year>2013</year> <month>10</month> <fpage>1185</fpage> <lpage>1193</lpage> <volume>154</volume> <issue>6</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.surg.2013.06.018</object-id></element-citation></ref><ref id="cit31"><element-citation><name><surname>La Salvia</surname> <given-names>Anna</given-names> </name> <name><surname>Lens-Pardo</surname> <given-names>Alberto</given-names> </name> <name><surname>López-López</surname> <given-names>Angel</given-names> </name> <name><surname>Carretero-Puche</surname> <given-names>Carlos</given-names> </name> <name><surname>Capdevila</surname> <given-names>Jaume</given-names> </name> <name><surname>Benavent</surname> <given-names>Marta</given-names> </name> <name><surname>Jiménez-Fonseca</surname> <given-names>Paula</given-names> </name> <name><surname>Castellano</surname> <given-names>Daniel</given-names> </name> <name><surname>Alonso</surname> <given-names>Teresa</given-names> </name> <name><surname>Teule</surname> <given-names>Alexandre</given-names> </name> <name><surname>Custodio</surname> <given-names>Ana</given-names> </name> <name><surname>Tafuto</surname> <given-names>Salvatore</given-names> </name> <name><surname>La Casta</surname> <given-names>Adelaida</given-names> </name> <name><surname>Spada</surname> <given-names>Francesca</given-names> </name> <name><surname>Lopez-Gonzalvez</surname> <given-names>Angeles</given-names> </name> <name><surname>Gil-Calderon</surname> <given-names>Beatriz</given-names> </name> <name><surname>Espinosa-Olarte</surname> <given-names>Paula</given-names> </name> <name><surname>Barbas</surname> <given-names>Coral</given-names> </name> <name><surname>Garcia-Carbonero</surname> <given-names>Rocio</given-names> </name> <name><surname>Soldevilla</surname> <given-names>Beatriz</given-names> </name> <article-title>Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival</article-title> <source>European Journal of Endocrinology</source> <year>2023</year> <month>11</month> <fpage>62</fpage> <lpage>74</lpage> <volume>190</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1093/ejendo/lvad160</object-id></element-citation></ref><ref id="cit32"><element-citation><name><surname>Fiehn</surname> <given-names>Oliver</given-names> </name> <article-title>Metabolomics by Gas Chromatography–Mass Spectrometry: Combined Targeted and Untargeted Profiling</article-title> <source>Current Protocols in Molecular Biology</source> <year>2016</year> <month>04</month> <volume>114</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1002/0471142727.mb3004s114</object-id></element-citation></ref><ref id="cit33"><element-citation><name><surname>Li</surname> <given-names>Xie</given-names> </name> <name><surname>Zhang</surname> <given-names>Yinan</given-names> </name> <name><surname>Xu</surname> <given-names>Lingyan</given-names> </name> <name><surname>Wang</surname> <given-names>Aoxue</given-names> </name> <name><surname>Zou</surname> <given-names>Yejun</given-names> </name> <name><surname>Li</surname> <given-names>Ting</given-names> </name> <name><surname>Huang</surname> <given-names>Li</given-names> </name> <name><surname>Chen</surname> <given-names>Weicai</given-names> </name> <name><surname>Liu</surname> <given-names>Shuning</given-names> </name> <name><surname>Jiang</surname> <given-names>Kun</given-names> </name> <name><surname>Zhang</surname> <given-names>Xiuze</given-names> </name> <name><surname>Wang</surname> <given-names>Dongmei</given-names> </name> <name><surname>Zhang</surname> <given-names>Lijuan</given-names> </name> <name><surname>Zhang</surname> <given-names>Zhuo</given-names> </name> <name><surname>Zhang</surname> <given-names>Zeyi</given-names> </name> <name><surname>Chen</surname> <given-names>Xianjun</given-names> </name> <name><surname>Jia</surname> <given-names>Wei</given-names> </name> <name><surname>Zhao</surname> <given-names>Aihua</given-names> </name> <name><surname>Yan</surname> <given-names>Xinfeng</given-names> </name> <name><surname>Zhou</surname> <given-names>Haimeng</given-names> </name> <name><surname>Zhu</surname> <given-names>Linyong</given-names> </name> <name><surname>Ma</surname> <given-names>Xinran</given-names> </name> <name><surname>Ju</surname> <given-names>Zhenyu</given-names> </name> <name><surname>Jia</surname> <given-names>Weiping</given-names> </name> <name><surname>Wang</surname> <given-names>Congrong</given-names> </name> <name><surname>Loscalzo</surname> <given-names>Joseph</given-names> </name> <name><surname>Yang</surname> <given-names>Yi</given-names> </name> <name><surname>Zhao</surname> <given-names>Yuzheng</given-names> </name> <article-title>Ultrasensitive sensors reveal the spatiotemporal landscape of lactate metabolism in physiology and disease</article-title> <source>Cell Metabolism</source> <year>2022</year> <month>10</month> <fpage>200</fpage> <lpage>211.e9</lpage> <volume>35</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1016/j.cmet.2022.10.002</object-id></element-citation></ref><ref id="cit34"><element-citation><name><surname>Bayode</surname> <given-names>Michael Tosin</given-names> </name> <name><surname>Alabi</surname> <given-names>Mercy Adewumi</given-names> </name> <name><surname>Ibisanmi</surname> <given-names>Temitope Abraham</given-names> </name> <name><surname>Okiti</surname> <given-names>Ayomide Faith</given-names> </name> <name><surname>Adebisi</surname> <given-names>Olabisi Omowumi</given-names> </name> <name><surname>Aro</surname> <given-names>Philemon Olayemi</given-names> </name> <name><surname>Awode</surname> <given-names>Ayoola Emmanuel</given-names> </name> <name><surname>Lawal</surname> <given-names>Oyindamola Sukurat</given-names> </name> <name><surname>Babatunde</surname> <given-names>Olamide Joshua</given-names> </name> <name><surname>Adenikinju</surname> <given-names>Gladys Oluwafisayo</given-names> </name> <article-title>Isothermal calorimetry calscreener in the metabolism gauge of human malignant neoplastic cells: a burgeoning nexus in cancer biochemical metrology and diagnostics</article-title> <source>Bulletin of the National Research Centre</source> <year>2023</year> <month>08</month> <volume>47</volume> <issue>1</issue> <object-id pub-id-type="doi" specific-use="metadata">10.1186/s42269-023-01097-8</object-id></element-citation></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
